Menu
"PV Fast Forward" - Technology, Pace, Priority.
Day 2 : Session 5 - Compliance Management
Session Chair(s)
Mangesh Kulkarni, MD
- Head Drug Safety
- Tata Consultancy Services, India
Speaker(s)
Session 5.1: Risk Minimisation Activities & Evalution of Effectiveness
Seema Jaitly, DrMed
- Managing Director
- Essjay Solutions Ltd, United Kingdom
Sesson 5.2: A risk based approach to real time compliance
Savitha Hanuman, MPharm
- VP. Accenture Life Sciences Operations
- Accenture, India
Session 5.3 : Indian Pharmacovigilance - Where do we stand today
J Vijay Venkatraman, MD, MBA
- Managing Director & CEO
- Oviya MedSafe Pvt Ltd, India
